Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Colorectal Disease|December 20, 2019
Implantation of tissue expander prior to irradiation in the era of intensity modulated radiotherapy: impact on the management of patients with pelvic digestive cancersLuc Ollivier, Jean Marc Guilloit, Mélanie Dos Santos, et al.
Annals of Surgical Oncology|November 25, 2025
Appendiceal Adenocarcinoma Discovered During Acute Perforated Appendicitis: A Potential Contribution of Prophylactic CRS and HIPEC-A French BIGRENAPE Group StudyElsa Leiritz, Jade Fawaz, Isabelle Sourrouille, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 7, 2020
Ovarian and peritoneal psammocarcinoma: Results of a multicenter study on 25 patientsJean-Baptiste Delhorme, Jordan Ohayon, Sébastien Gouy, et al.
BMC Cancer|May 13, 2022
Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR)Mélanie Dos Santos, Justine Lequesne, Alexandra Leconte, et al.
Annals of Surgical Oncology|July 25, 2019
Watch and Wait Approach for Re-excision After Unplanned Yet Macroscopically Complete Excision of Extremity and Superficial Truncal Soft Tissue Sarcoma is Safe and Does Not Affect Metastatic Risk or Amputation RateGauthier Decanter, Eberhard Stoeckle, Charles Honore, et al.
European Journal of Cancer (Oxford, England : 1990)|February 7, 2026
Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): Results from the GASPAR phase 2 studyMélanie Dos Santos, Justine Lequesne, Guillaume Piessen, et al.
The Lancet. Oncology|July 28, 2020
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 studyDiane Goéré, Olivier Glehen, François Quenet, et al.
Annals of Surgical Oncology|September 8, 2016
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis in the Elderly: A Case-Controlled, Multicenter StudyMohammad Alyami, Peter Lundberg, Vahan Kepenekian, et al.
Annals of Surgery|August 2, 2021
Half of Postoperative Deaths After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Could be Preventable: A French Root Cause Analysis on 5562 PatientsConstance Houlzé-Laroye, Olivier Glehen, Olivia Sgarbura, et al.
The Lancet. Oncology|November 16, 2024
Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trialJean-Marc Classe, Pierre Meeus, Delphine Hudry, et al.
Pageof 3